Current Drug Discovery Technologies

Editor-in-Chief

Vladimir P. Torchilin
(68301 citations)
Department of Pharmaceutical Science Center for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, MA 02115
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Editorial [Hot Topic: New Anticoagulant Drugs: A Change of Paradigm? (Guest Editor: Antonio Gomez-Outes)] promotion: free to download

Volume:9   Issue: 2
Pp: 81-82
Antonio Gomez-Outes
DOI: 10.2174/1570163811209020081
Published on: 03 April, 2012

Discovery of Anticoagulant Drugs: A Historical Perspective

Volume:9   Issue: 2
Pp: 83-104
Antonio Gomez-Outes, M Luisa Suarez-Gea, Gonzalo Calvo-Rojas, Ramon Lecumberri, Eduardo Rocha, Carmen Pozo-Hernandez, Ana Isabel Terleira-Fernandez and Emilio Vargas-Castrillon
DOI: 10.2174/1570163811209020083
Published on: 03 April, 2012

Clinical Drug Development in Thromboembolic Diseases: Regulatory and Methodological Approach

Volume:9   Issue: 2
Pp: 105-118
Gonzalo Calvo-Rojas and Antonio Gomez-Outes
DOI: 10.2174/1570163811209020105
Published on: 03 April, 2012

New Oral Anticoagulants for Venous Thromboembolism: Focus on Factor Xa and Thrombin Inhibitors

Volume:9   Issue: 2
Pp: 119-128
Cecilia Becattini, Alessandra Lignani and Giancarlo Agnelli
DOI: 10.2174/1570163811209020119
Published on: 03 April, 2012

New Parenteral Anticoagulants: Focus on Factor Xa and Thrombin Inhibitors

Volume:9   Issue: 2
Pp: 129-136
Ingo Ahrens and Christoph Bode
DOI: 10.2174/1570163811209020129
Published on: 03 April, 2012

Regulatory Considerations for Generic or Biosimilar Low Molecular Weight Heparins

Volume:9   Issue: 2
Pp: 137-142
Alfredo Garcia-Arieta and Antonio Blazquez
DOI: 10.2174/1570163811209020137
Published on: 03 April, 2012

Reversing Anticoagulant Therapy

Volume:9   Issue: 2
Pp: 143-149
Shari Ghanny, Theodore E. Warkentin and Mark A. Crowther
DOI: 10.2174/1570163811209020143
Published on: 03 April, 2012

New Targets for Anticoagulation and Future Perspectives

Volume:9   Issue: 2
Pp: 150-155
Jack Ansell and David Askin
DOI: 10.2174/1570163811209020150
Published on: 03 April, 2012